Chen, H., Kuhn, J., Lamborn, K. R., Abrey, L. E., DeAngelis, L. M., Lieberman, F., . . . Gilbert, M. R. (2020). Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Neurooncol Adv.
Citação norma ChicagoChen, Huanwen, et al. "Phase I/II Study of Sorafenib in Combination With Erlotinib for Recurrent Glioblastoma As Part of a 3-arm Sequential Accrual Clinical Trial: NABTC 05-02." Neurooncol Adv 2020.
Citação norma MLAChen, Huanwen, et al. "Phase I/II Study of Sorafenib in Combination With Erlotinib for Recurrent Glioblastoma As Part of a 3-arm Sequential Accrual Clinical Trial: NABTC 05-02." Neurooncol Adv 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.